J Steroid Biochem Mol Biol. 2012 Oct 8. pii: S0960-0760(12)00200-2. doi: 10.1016/j.jsbmb.2012.09.031. Epub ahead of print
Luo W, Hershberger PA, Trump DL, Johnson CS.
Department of Pharmacology and Therapeutics.
The active vitamin D hormone 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) plays a major role in regulating calcium homeostasis and bone mineralization. 1,25(OH)(2)D(3) also modulates cellular proliferation and differentiation in a variety of cell types. 24-hydroxylase, encoded by the CYP24A1 gene, is the key enzyme which converts 1,25(OH)(2)D(3) to less active calcitroic acid.
Nearly all cell types express 24-hydroxylase, the highest activity being observed in the kidney.
There is increasing evidence linking the incidence and prognosis of certain cancers to low serum 25 (OH)D(3) levels and high expression of vitamin D 24-hydroxylase supporting the idea that elevated CYP24A1 expression may stimulate degradation of vitamin D metabolites including 25-(OH)D(3) and 1,25(OH)(2)D(3).
The over expression of CYP24A1 in cancer cells may be a factor affecting 1,25(OH)(2)D(3) bioavailability and anti-proliferative activity pre-clinically and clinically.
The combination of 1,25(OH)(2)D(3) with CYP24A1 inhibitors enhances 1,25(OH)(2)D(3) mediated signaling and anti-proliferative effects and may be useful in overcoming effects of aberrant CYP24 expression.
Copyright © 2012. Published by Elsevier Ltd.
- - - - - - - - - - - - - -
- 3X higher risk of one cancer if CYP27B1 and CYP24A1 genes were different – May 2012
- Search for CYP27B1 OR CYP24A1 in VitaminDWiki 362 items as of Oct 2012
- All items in category Genetics and Vitamin D
- Vitamin D insufficiency 2.5X more likely with three genes – Lancet July 2010
- CYP24A1 enzyme and Vitamin D many papers and links
- Pharmacology of vitamin D - April 2011 which has the following graphic